A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

NCT04927065 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

5161

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL: mRNA-1273.211
BIOLOGICAL: mRNA-1273
BIOLOGICAL: mRNA-1273.617.2
BIOLOGICAL: mRNA-1273.213
BIOLOGICAL: mRNA-1273.529
BIOLOGICAL: mRNA-1273.214
BIOLOGICAL: mRNA-1273.222
BIOLOGICAL: mRNA-1273.815
BIOLOGICAL: mRNA-1273.231

Sponsor

ModernaTX, Inc.